tiprankstipranks
Holista Colltech Limited (AU:HCT)
ASX:HCT
Australian Market

Holista Colltech Limited (HCT) AI Stock Analysis

Compare
2 Followers

Top Page

AU:HCT

Holista Colltech Limited

(Sydney:HCT)

Select Model
Select Model
Select Model
Underperform 39 (OpenAI - 5.2)
Rating:39Underperform
Price Target:
AU$0.06
▼(-34.44% Downside)
Action:DowngradedDate:03/06/26
The score is primarily weighed down by weak financial performance (declining revenue, worsening losses, and persistent negative operating/free cash flow) alongside bearish technicals (below key moving averages with negative MACD). Valuation provides limited support due to the negative P/E and lack of dividend yield data.
Positive Factors
Balance Sheet Improvement
Equity turning positive in 2025 indicates a repaired capital base versus prior years, lowering insolvency risk and improving the firm's structural ability to raise funds or absorb losses. This enhances counterparties’ confidence and provides a firmer platform for medium-term recovery and partnerships.
Negative Factors
Negative Cash Generation
Persistent negative operating and free cash flow, worsening in 2025, creates ongoing cash burn and financing dependency. Structurally weak cash generation limits ability to fund operations, invests in growth, or withstand shocks without dilutive or costly external financing, posing medium-term solvency and execution risks.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Improvement
Equity turning positive in 2025 indicates a repaired capital base versus prior years, lowering insolvency risk and improving the firm's structural ability to raise funds or absorb losses. This enhances counterparties’ confidence and provides a firmer platform for medium-term recovery and partnerships.
Read all positive factors

Holista Colltech Limited (HCT) vs. iShares MSCI Australia ETF (EWA)

Holista Colltech Limited Business Overview & Revenue Model

Company Description
Holista CollTech Limited operates as a biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection control Solutions, and Food Ingredients segments. It manufactures and wholesa...
How the Company Makes Money
Holista Colltech Limited generates revenue through multiple streams, primarily by selling its proprietary health and wellness products to consumers and businesses. The company has established key partnerships with distributors and retailers, enabl...

Holista Colltech Limited Financial Statement Overview

Summary
Financials indicate significant strain: sharp revenue contraction in the latest period, worsening profitability with negative operating profit and a -16.5% net margin, and persistent cash burn (negative operating cash flow and free cash flow across all years, deteriorating further in 2025). Balance sheet equity has turned positive again, but leverage remains high relative to equity, keeping funding risk elevated.
Income Statement
24
Negative
Balance Sheet
38
Negative
Cash Flow
18
Very Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.76M5.60M5.95M8.24M8.02M
Gross Profit770.25K87.03K370.06K4.24M1.31M
EBITDA-788.46K304.37K-4.52M-1.02M-957.40K
Net Income-948.92K-84.21K-4.81M-1.45M-1.26M
Balance Sheet
Total Assets5.87M3.34M3.35M5.52M6.93M
Cash, Cash Equivalents and Short-Term Investments2.16M21.72K59.77K117.53K1.21M
Total Debt1.59M1.77M1.57M1.22M890.32K
Total Liabilities6.29M6.71M6.74M3.96M3.95M
Stockholders Equity1.12M-1.73M-1.97M2.83M4.10M
Cash Flow
Free Cash Flow-1.52M-1.02M-411.67K-1.19M-1.72M
Operating Cash Flow-1.35M-1.01M-407.12K-1.11M-1.68M
Investing Cash Flow-176.36K692.12K-46.70K-105.69K50.35K
Financing Cash Flow3.65M143.75K418.42K120.85K109.49K

Holista Colltech Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.07
Negative
100DMA
0.08
Negative
200DMA
0.08
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
10.04
Positive
STOCH
37.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:HCT, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.07, and above the 200-day MA of 0.08, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 10.04 is Positive, neither overbought nor oversold. The STOCH value of 37.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:HCT.

Holista Colltech Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
AU$35.84M22.20-53.68%-15.07%29.45%
44
Neutral
AU$7.57M-4.69-35.12%63.30%70.00%
41
Neutral
AU$5.53M-0.92-92.72%39.53%49.99%
41
Neutral
AU$7.69M-1.62-44.35%-18.70%20.83%
39
Underperform
AU$23.17M-33.08-321.20%6.76%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:HCT
Holista Colltech Limited
0.06
0.03
103.23%
AU:WNX
Wellnex Life Ltd
0.08
-0.40
-83.37%
AU:EVE
EVE Health Group Limited
0.02
>-0.01
-26.67%
AU:OMG
Forbidden Foods Ltd
0.01
0.00
0.00%
AU:MBH
Maggie Beer Holdings Ltd.
0.08
0.02
29.03%

Holista Colltech Limited Corporate Events

Holista Colltech lifts revenue and margins but one-off legal costs drive FY2025 loss
Feb 27, 2026
Holista Colltech reported a 3% rise in full-year 2025 revenue to about $5.8 million, driven mainly by an 11.4% increase in dietary supplements sales and favourable foreign exchange movements, despite a sharp fall in food ingredients revenue. Gross...
Holista Colltech Delivers Positive Cash Flow and Strong Liquidity Amid Softer Market
Jan 30, 2026
Holista Colltech reported a return to positive operating cash flow in the December 2025 quarter, delivering a net operating cash inflow of $238,000 supported by a 26.8% quarter-on-quarter reduction in operating costs to $1.46 million, despite one-...
Holista Colltech Faces $1.09 Million Legal Cost Claim from ASIC
Dec 10, 2025
Holista Colltech Limited has received a notice from the Australian Securities and Investments Commission (ASIC) seeking recovery of legal costs amounting to approximately $1.09 million following Federal Court proceedings. The company is currently ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 06, 2026